H. Popper (Graz, Austria), P. Schnabel (Heidelberg, Germany)
Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition
J. Schwartze, L. Wujak, W. Seeger, N. Kneidinger, R. Morty (Giessen, Germany)
|  |
Hypoxia-induced methylation of the Thy-1 promoter is associated with transcriptional repression in human primary lung fibroblasts
C. Robinson, C. Watson, A. Levendale, M. Xu, J. Baugh (Dublin, Ireland)
| |
Relationship between levels of IL-6 in the lungs in patients with idiopathic interstitial pneumonia and polymorphism -174 G / C promoter of the IL6 gene
E. Marquez-Martin, V. Friaza, L. Rivero, M. Montes-Cano, C. de la Horra, J. Martin, E. Rodriguez-Becerra, E. Calderon (Seville, Spain)
| |
Drug target expression in pulmonary langerhans´cell histiocytosis
J. Loeffler-Ragg, E. Stacher, J. Guenther, P. Stoitzner, K. Cima, S. Desole, H. H. Popper, C. M. Kaehler (Austria)
| |
The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients
S. Schmid, S. Noeske, A. Hattesohl, T. Greulich, R. Bals, C. Vogelmeier, A. R. Koczulla (Germany)
| |
The role of RAS genes polymorphism in the development risk of RDS in newborns
S. Kyryachenko, N. Gorovenko, Z. Rossokha, S. Podolskaya (Kiev, Ukraine)
|  |
CIBERES: Pulmonary biobank consortium
C. Villena, J. Sauleda, F. Pozo, J. Cortijo, A. Esteban, A. Rosell, J. Gea, J. A. Barberà, G. Peces-Barba, E. Monsó, J. Rello, A. Agustí (Ciberes, Palma de Mallorca, Madrid, Valencia, Barcelona, Badalona, Spain)
| |
Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed
G. Karoubi, L. Cortes-Dericks, G. Carboni, R. Schmid (Switzerland)
| |
MicroRNA in diagnosis and prevention of smoke related lung diseases
A. Izzotti (Genoa, Italy)
| |
A role of matrix metalloproteinases and their inhibitors in the pathogenesis of fibrosis and angiogenesis in lung precancer processes
G. Sagindikova, E. Kogan (Russian Federation)
| |
Differential regulation of TNF-α and TGF- β production by PAI-1 in lung cancer and endothelial cells
J. Chorostowska-Wynimko, M. Kedzior, R. Struniawski, B. Gruber, E. Anuszewska, E. Skrzypczak-Jankun, J. Jankun (Warsaw, Poland; , United States Of America)
| |
Can molecular markers (EGFR, ERCC1) serve as screening parameters for adjuvant chemotherapy decision in early staged non-small cell lung cancer patients?
R. Zinsky, S. Scheil-Bertram, S. Bölükbas, J. Schirren, A. Fisseler (Wiesbaden, Germany)
| |
Is MIF -173G/C polymorphism associated with in non-small cell lung cancer (NSCLC) susceptibility?
M. Gomes, A. Coelho, A. Araújo, R. Catarino, R. Medeiros (Porto, Portugal)
| |
The in vitro study of anticancer new-structure compound, Bostrycin(1403C), from marine fungi, as AKT molecule target for lung cancer
Y. Guo, W. Chen, H. Yang, Z. She, C. Xie (Guangzhou, China)
| |
Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
A. Sanchez-Palencia, M. Gomez-Morales, J. A. Gomez-Capilla, L. Boyero-Corral, M. E. Farez-Vidal (Granada, Spain)
| |
Survivin expression in non-small cell lung cancer
I. Porebska, E. Sobanska, E. Wyrodek, M. Kosacka, R. Jankowska (Wroclaw, Poland)
| |
Microarray and protein biomarker analysis of endobronchial epithelial lining fluid (EELF) in the evaluation of indeterminate pulmonary nodules (IPN)
N. Kahn, R. Kuner, R. Eberhardt, M. Meister, T. Muley, S. Winteroll, P. Schnabel, F. Herth, H. Sueltmann, H. Hoffmann (Heidelberg, Germany)
| |
LSC 2010 Abstract: Real-time PCR quantification of free-circulating plasma DNA in resectable NSCLC and chronic inflammatory respiratory diseases
A. Szpechcinski, R. Struniawski, T. Orlowski, E. Puscinska, P. Bielen, J. Chorostowska-Wynimko (Warsaw, Poland)
| |
Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients
K. Darwiche, J. I. Baumbach, B. Boedeker, O. Anhenn, U. Sommerwerck, L. Freitag (Dortmund, Germany)
| |